Facebook

Twitter

abstracts
 

 

 

 

Important Dates

31 January 2014 Abstract submission site opens
28 April 2014 Abstract deadline
29 April 2014 Late-breaking abstract submission site opens
30 June 2014 Late-breaking abstract deadline
11 September 2014 Poster Session I
12 September 2014 Poster Session II
13 September 2014 Best Poster & Best Young Investigator Oral Presentation Awards


Learn about groundbreaking research and treatments at MSBoston2014

Abstract presentations announced

A record-breaking 1,727 abstracts were submitted for consideration for MS Boston 2014, the joint meeting of America’s and Europe’s Committees for the Treatment and Research in Multiple Sclerosis. Of those, the top 94 abstracts were selected for platform presentations and an additional 980 were selected for poster sessions. Seven were selected for late-breaking platform presentations and 22 were selected for eposter presentation.
Each of the 1,727 abstracts was reviewed by a scientific review committee of three experts. The abstracts were selected on the basis of novelty, interest, scientific merit, and relevance to one of 12 meeting themes.

The joint meeting, to be held 10 – 13 September in Boston, Mass., U.S., is largest gathering of its kind for multiple sclerosis researchers and clinicians with attendees from over ninety countries expected to attend.

The topics selected represent the leading edge of multiple sclerosis research and treatment therapies. Presenters include researchers and clinicians from leading institutions throughout the world.

A complete list of the oral presentations and posters appears on the conference session planner.

Poster topics presented at MS Boston 2014

  • Caregivers, employment, and healthcare utilization
  • Clinical outcome measures
  • Clinical trials
  • Cognitive function
  • Comorbidities and risk behaviors
  • CSF studies
  • Databases
  • Diagnosis and differential diagnosis
  • Disease biomarkers
  • Disease therapy
  • Epidemiology
  • Experimental models
  • Genetics and epigenetics
  • Imaging
  • Immunology
  • Internet and social media
  • Microbiome
  • Neurobiology
  • Neuromyelitis optica
  • Neuro-ophthalmology and OCT
  • Neuropathology
  • Neurophysiology
  • Neuroprotection and repair
  • Neuropsychiatric aspects
  • Pediatric MS
  • Prognostic factors
  • PROs and QOL
  • Rehabilitation and comprehensive care
  • Reproductive aspects and pregnancy
  • Risk management for disease therapies
  • Stem cells and cell-based therapy
  • Symptom management
  • Treatment biomarkers, pharmacology, and MOA


Poster Printing Service

CALL4POSTERS® - CONVENIENCE IN POSTER PRINTING

image for poster printing service SAMPLEThe 2014 Joint ACTRIMS-ECTRIMS Meetings (MS Boston 2014) has partnered with Learner’s Digest International to provide presenting authors of accepted posters with the opportunity to create their poster online using the Call4Posters® service. This optional service is an easy and convenient way for presenters to prepare their poster for the Joint Meeting! It is not required for presenting authors to use this poster service; it is suggested that you take advantage of it. 

Options and benefits:
• Free templates are available for download to make the poster creation process as easy as possible. Customer support is available during regular business hours to assist with questions.
• Call4Posters will print the poster according to the meeting specifications.
• The poster will be shipped to the meeting and presenters will be able to pick up their poster onsite and avoid the inconvenience of traveling to the meeting with their poster. It will be there waiting for the presenter.
• Call4Posters staff on site can mount your poster for you at the appropriate set up time as an optional service.

Presenting authors would have received a separate email from ACTRIMS Poster Printing Service This email address is being protected from spambots. You need JavaScript enabled to view it. which included a link and instructions on how to prepare and upload posters for poster printing.  To access this service, click here.


Submit a Late Breaking Abstract - now closed

Click here to submit your late breaking abstract. We strongly recommend bookmarking this separate website for easy future access.


Preparation of Abstracts

  • The deadline for abstract submission is 28 April 2014, 23:59 CST.
  • Abstracts must be submitted online only. Abstracts submitted by fax or email will not be accepted.
  • Please follow the instructions provided on the abstract submission website.
  • Abstracts must be submitted in English. Please use American English spelling.
  • Abstracts should contain only original material not published or presented elsewhere prior to 10 September 2014.
  • Provide a short specific title indicating the nature of the investigation. The abstract text contains five mandatory sections: background, objectives, methods, results and conclusions. The results must contain data.
  • The title may not exceed 150 characters including spaces. The abstract text may not exceed 2500 characters including spaces.
  • All abbreviations must be defined the first time they appear in the text, e.g. Multiple Sclerosis Impact Scale (MSIS). Do not define abbreviations in the title.
  • Avoid complex mathematical formulae. Use the abstract submission website functions for Greek letters, mathematical symbols, special characters and formatting.
  • Use generic drug names.
  • Tables, charts, or other graphics may not be included and will be deleted.
  • Authors should indicate their presentation preference:
    • Poster presentation only
    • Platform or poster presentation

Note: “Poster presentation only” implies that your abstract will not be eligible for a Best Poster prize (see Awards), for which winners make a short platform presentation during the Closing Session.

The Scientific Program Committee reserves the right to decide the final allocation and presentation method.

If you have questions regarding abstracts or need assistance, please contact the abstract team at This email address is being protected from spambots. You need JavaScript enabled to view it. or call the Abstract Hotline (Monday – Friday during 01:30-10:30 CST / 08:30-17:30 CET business hours): Tel. +49 511 549 0044.


Meeting Themes

The 2014 Joint ACTRIMS-ECTRIMS Meeting will address aspects of multiple sclerosis related to the following themes:

  1. Diagnosis, phenotypes, and variants of MS and related disorders
  2. Factors that determine MS susceptibility, disease course, and prognosis: The roles and interactions of genetics, epigenetics, the microbiome, environmental factors, pregnancy, age, comorbidities, and risk behaviors in determining MS susceptibility and disease course
  3. Pathogenesis of MS relapses and progression: The link between inflammation and neurodegeneration
  4. Mechanisms, detection, and significance of gray matter pathology in MS
  5. Methods to monitor MS disease activity and severity: Patient self-report and automated self-assessment, new clinician-reported outcomes, standard and advanced imaging, and biomarkers
  6. Current, emerging, and future disease therapies for relapsing-remitting and progressive MS and related disorders
  7. Treatment strategies: Early treatment, switching therapies, treating-to-target of no evidence of disease activity, personalized treatment, and post-marketing monitoring of safety and efficacy
  8. Regeneration and repair: Which strategies look promising and how do we test them
  9. Aspects of trial design in relapsing and progressive MS
  10. Rehabilitative strategies to restore function: Improving cognition, motor function, and mobility
  11. Management of the symptoms and other sequelae of MS
  12. Society and MS: Roles of the expert patient, social media, and health policy

Requirements for Continuing Medical Education

This meeting will be jointly sponsored by ACTRIMS-ECTRIMS and, for the purpose of providing continuing medical education (CME) credit, the Consortium of Multiple Sclerosis Centers (CMSC).

CMSC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) as a provider of CME for physicians. Any CME accredited activity must serve to maintain, develop, or increase knowledge, skills, professional performance, and relationships that a physician uses to provide services for patients, the public, or the profession.  The content of CME is the body of knowledge and skills generally recognized and accepted by the profession as within the basic medical sciences, the discipline of clinical medicine, and the provision of healthcare to the public.

The rules governing eligibility of scientific meetings for CME are complicated and continually evolving, in particular the rules related to submissions involving commercial interests (as defined by the ACCME).  Please note the following policies concerning abstracts for this meeting, some of which may differ from those of other scientific meetings you may have attended.

Abstracts accepted for platform presentations, for which CME credits will be offered, will be designated as such and will be clearly distinguished from non-CME work.  For your submission to be included in a plenary session that meets the requirements for AMA Category I credit and adheres to ACCME guidelines, it must meet each of the following criteria:

  1. No author may be an employee of a commercial interest, except under certain very specific circumstances that will require prior approval by our joint sponsors.
  2. The abstract, presentation, or slides may not be written, prepared, or produced by a commercial interest.
  3. The submission must be non-promotional in nature.
  4. The content must be appropriate in depth and scope for the intended physician audience.
  5. All authors must complete and sign the disclosure form

Submissions accepted for posters will not be categorized into those eligible for CME and those that are not.  Thus, CME will not be offered for the poster sessions.


Abstracts with Authors Employed by Commercial Interests

Abstracts with authors who are employees of commercial interests, including abstracts solely from commercial interests, will be considered for the meeting, but only for non-CME presentations.

Abstracts reporting results from collaborative research conducted by both independent (non-company) investigators and investigators who are employees of commercial interests will not be accepted unless the independent investigators (academic, clinician, and/or scientist) are included as authors.


Notification

Each abstract will be reviewed by 3-4 external experts and then by the Scientific Program Committee. Notification of acceptance or rejection of submitted abstracts will be sent to the corresponding authors via email in July 2014.  Full instructions concerning poster or platform presentation of accepted abstracts will be included and available on the Meeting website.


Meeting Attendance and Presentation

The presenting author of an accepted abstract must register and attend the Meeting.

Poster presenters must be present and stand by their posters during their assigned poster sessions.

Authors accepted for platform presentations will be invited to make a 10-minute presentation followed by questions.

Full instructions concerning poster or platform presentation of accepted abstracts will be included in the notification letter and available on the Meeting website.


Posters Preparation

Full instructions concerning poster preparation of accepted abstracts will be included in the notification letter and available on the Meeting website at a later date. Check the website often for updates.

The use of QR codes linking to a PDF of the poster is allowed. QR codes can also be linked to the Joint Meeting website where a copy of the poster will be posted close to meeting date. No other external linking is permitted. The use of AR codes on a poster is allowed. However, links to promotional material related to a commercial interest or product is strictly prohibited.


Publication of Abstracts

All accepted abstracts will be published in the Multiple Sclerosis Journal Online as well as on the website of the 2014 Joint ACTRIMS-ECTRIMS Meeting, on the application for smart phone devices, and a USB memory stick available at the Meeting.

Full text of regular abstracts will be published ten days prior to the Meeting on the Meeting website.


Presentations Available on the ACTRIMS Website

We plan to post posters or slides of accepted presentations on the website of the 2014 Joint ACTRIMS-ECTRIMS Meeting after the Meeting.

The corresponding authors of abstracts accepted for poster presentations will be asked to provide a PPT or PDF file of their poster.

The corresponding authors of abstracts accepted for platform presentations will be asked for permission to post their slides at the time the PPT file is uploaded.  If you do not agree, please click the appropriate checkbox during the slide submission.


Opportunities for Young Investigators

Young Investigator Sessions

Abstracts submitted by presenting authors who are age 35 or younger (born on or after 01 January 1979) may be considered for the Young Investigators Sessions. Selected presenters will be invited to give a platform presentation followed by discussion.  If you wish to be considered for this session, please click the appropriate checkbox during the online abstract submission process.  You will be required to upload an image or picture (PDF, JPG, GIF) documenting your date of birth as proof of eligibility (e.g. driver’s license or passport, etc.).

Abstracts without proof of date of birth submitted by the abstract deadline on 28 April 2014, 23:59 CST will not be considered for presentation during the Young Investigator Sessions.

If you have difficulties uploading your proof of date of birth, please contact the abstract team at This email address is being protected from spambots. You need JavaScript enabled to view it. or call the Abstract Hotline (Monday – Friday during 01:30 – 10:30 CST / 08:30-17:30 CET business hours): Tel. +49 511 549 0044.

Educational Grants

A limited number of 2014 Joint ACTRIMS-ECTRIMS Meeting Educational Grants will be made available to Young Investigators age 35 or younger (born on or after 01 January 1979) whose abstracts are accepted for platform or poster presentation.  If you wish to be considered for an educational grant, please click the appropriate checkbox during the online abstract submission process.  You will be required to upload an image or picture (PDF, JPG, GIF) documenting that your date of birth as proof of eligibility (e.g. driver’s license or passport, etc.).

Applications for Educational Grants without proof of date of birth submitted by the abstract deadline on 28 April 2014, 23:59 CST will not be considered.

If you have difficulties uploading your proof of date of birth, please contact the abstract team at This email address is being protected from spambots. You need JavaScript enabled to view it. or call the Abstract Hotline (Monday – Friday during 01:30 – 10:30 CST / 08:30-17:30 CET business hours): Tel. +49 511 549 0044.

Recipients of Educational Grants will be notified in July 2014, after notification of abstract acceptance.  Those who are awarded an Educational Grant will receive $500 USD and free registration to the Meeting.

Applications for Educational Grants will not be accepted for authors of Late Breaking News abstracts.


Awards

Best Posters

Prizes will be awarded for the five best poster presentations ($1500 USD each).  Award-winning poster authors will give a short presentation during the Closing Session Saturday, 13 September 2014.

Best Young Investigator Oral Presentations

Two prizes ($2000 USD each) will be awarded for the best oral presentations given by Young Investigators age 35 or younger (born on or after 01 January 1979).  Prizes will be announced during the Closing Session Saturday, 13 September 2014.  If you wish to be considered for this award, please click the appropriate checkbox during the online abstract submission process.  You will be required to upload an image or picture (PDF, JPG, GIF) documenting that your date of birth as proof of eligibility (e.g. driver’s license or passport, etc.).

Applications for Young Investigator Awards without proof of date of birth submitted by the abstract deadline on 28 April 2014, 23:59 CST will not be considered.

If you have difficulties uploading your proof of date of birth, please contact the abstract team at This email address is being protected from spambots. You need JavaScript enabled to view it. or call the Abstract Hotline (Monday – Friday during 01:30 – 10:30 CST / 08:30-17:30 CET business hours): Tel. +49 511 549 0044.

Additional Prizes

Additional prizes will be awarded by the MS International Federation and Multiple Sclerosis Journal during the Closing Session Saturday, 13 September 2014.


Late Breaking News Abstracts

The online Late Breaking News abstract submission website will open after the regular abstract submission website closes.  The deadline for Late Breaking News abstract submission is 30 June 2014, 23:59 CST.

The process for submitting Late Breaking News abstracts will be similar to that of regular abstracts (see Preparation of abstracts).

If you have questions regarding abstracts or need assistance, please contact the abstract team at This email address is being protected from spambots. You need JavaScript enabled to view it. or call the Abstract Hotline (Monday – Friday during 01:30 – 10:30 CST / 08:30-17:30 business hours): Tel. +49 511 549 0044.

A select number of Late Breaking News abstracts will be accepted for oral presentation during the Late Breaking News session Saturday, 13 September 2014.  The remaining accepted abstracts will be presented as e-posters. Poster presenters must be present during the Late Breaking News poster session Saturday, 13 September 2014.

Notification of acceptance or rejection of submitted Late Breaking News abstracts will be sent to the corresponding authors via email in July 2014.  Full instructions concerning e-poster or platform presentation of accepted abstracts will be included and available on the Meeting website.

The presenting author of an accepted Late Breaking News abstract must register and attend the Meeting.

All accepted Late Breaking News abstracts will be published in the Multiple Sclerosis Journal Online as well as on the website of the 2014 Joint ACTRIMS-ECTRIMS Meeting, on the application for smart phone devices, and a USB memory stick available at the Meeting.

Late Breaking News abstracts will be published on the Meeting website on the first day of the Meeting.


 

ACTRIMS SECRETARIAT

For more information on the program, support opportunities, or any general questions, please contact the ACTRIMS Secretariat.

ACTRIMS
22 North Carroll Street, Suite 300
Madison, Wisconsin 53703 USA

+ 1 608 310 8960
info@actrims.org

Logistics Secretariat

For more information about housing, registration, press, media and Boston in general, please contact the Logistics Secretariat.

c/o Opus 3 inc.
417 Saint-Pierre Street, Suite 302
Montréal QC H2Y 2M4 Canada

+ 1 514 395 1808
info@msboston2014.org

opus logo